Historical source coverage

2009

31 selected records with a cited source date in 2009. This archive is selective and does not imply continuous monitoring or complete historical coverage.

Explore 2009 by record type

3 types

December 2009

2 records

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00063310

PeptideScanner retained ClinicalTrials.gov record NCT00063310 at 2026-07-30T22:26:45.017Z. Its registry update date was 2009-12-11, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

→

Regulatory · Desmopressin

Federal Register notice E9-28593

The Federal Register published notice E9-28593, attributed to FDA and its parent HHS department, on 2009-12-01. Its official title is “Draft and Revised Draft Guidances for Industry Describing Product-Specific Bioequivalence Recommendations; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Desmopressin.

Source: Federal Register via GovInfo ↗

→

November 2009

3 records

Literature metadata · PEG-MGF

A new pro-migratory activity on human myogenic precursor cells for a synthetic peptide within the E domain of the mechano growth factor.

PubMed lists PMID 17156777 in Experimental cell research as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2006-11-07 (day precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Nesiritide

ClinicalTrials.gov record NCT00170183

PeptideScanner retained ClinicalTrials.gov record NCT00170183 at 2026-11-16T01:39:41.882Z. Its registry update date was 2009-11-16, and PeptideScanner's reviewed identity mapping was nesiritide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Gonadorelin

[Comparative clinico-therapeutic study of gonadorelin and chorionic gonadotropin in boys with undescended testes].

PubMed lists PMID 2885699 in Lijecnicki vjesnik as Clinical Trial, Comparative Study, English Abstract, Journal Article, with publication-date metadata of 1987 Feb-Mar (source-text precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

October 2009

5 records

Literature metadata · Octreotide

PubMed record PMID 19864727

PeptideScanner retained PubMed bibliographic metadata for PMID 19864727 at 2026-07-30T22:27:39.979Z. PubMed recorded a metadata revision date of 2009-10-29 and an Entrez history date of 2009-10-30. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Octreotide

PubMed record PMID 19864763

PeptideScanner retained PubMed bibliographic metadata for PMID 19864763 at 2026-07-30T22:27:39.979Z. PubMed recorded a metadata revision date of 2009-10-29 and an Entrez history date of 2009-10-30. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00414973

PeptideScanner retained ClinicalTrials.gov record NCT00414973 at 2026-07-30T22:26:45.016Z. Its registry update date was 2009-10-28, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Dalbavancin

ClinicalTrials.gov record NCT00678106

PeptideScanner retained ClinicalTrials.gov record NCT00678106 at 2026-11-16T17:37:42.807Z. Its registry update date was 2009-10-12, and PeptideScanner's reviewed identity mapping was dalbavancin.

Source: ClinicalTrials.gov ↗

→

September 2009

3 records

Clinical trials · Afamelanotide

ClinicalTrials.gov record NCT00859534

PeptideScanner retained ClinicalTrials.gov record NCT00859534 at 2026-07-30T22:26:45.018Z. Its registry update date was 2009-09-15, and PeptideScanner's reviewed identity mapping was afamelanotide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Secretin

Focus on the splicing of secretin GPCRs transmembrane-domain 7.

PubMed lists PMID 19733082 in Trends in biochemical sciences as Journal Article, Review, with publication-date metadata of 2009-09-03 (day precision). PeptideScanner associated the retained record with the identity slug secretin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

August 2009

2 records

Literature metadata · Mecasermin

Allergic reaction to mecasermin.

PubMed lists PMID 19663134 in Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology as Case Reports, Letter, with publication-date metadata of 2009-07 (month precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Exenatide

PubMed record PMID 19588557

PeptideScanner retained PubMed bibliographic metadata for PMID 19588557 at 2026-07-30T22:27:39.924Z. PubMed recorded a metadata revision date of 2009-08-04 and an Entrez history date of 2009-07-10. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

July 2009

1 record

Clinical trials · Thymosin alpha-1

ClinicalTrials.gov record NCT00911443

PeptideScanner retained ClinicalTrials.gov record NCT00911443 at 2026-11-15T22:10:40.222Z. Its registry update date was 2009-07-09, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

Source: ClinicalTrials.gov ↗

→

June 2009

3 records

Regulatory · Leuprolide

Federal Register notice E9-13272

The Federal Register published notice E9-13272, attributed to FDA and its parent HHS department, on 2009-06-08. Its official title is “Draft and Revised Draft Guidances for Industry Describing Product-Specific Bioequivalence Recommendations; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide.

Source: Federal Register via GovInfo ↗

→

Literature metadata · Octreotide

PubMed record PMID 20641226

PeptideScanner retained PubMed bibliographic metadata for PMID 20641226 at 2026-07-30T22:27:39.988Z. PubMed recorded a metadata revision date of 2009-06-05 and an Entrez history date of 2009-06-05. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

May 2009

7 records

Literature metadata · Degarelix

Degarelix for prostate cancer.

PubMed lists PMID 19453267 in Expert opinion on investigational drugs as Journal Article, Review, with publication-date metadata of 2009-06 (month precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Regulatory · Oxytocin + 1 more

Federal Register notice E9-11628

The Federal Register published notice E9-11628, attributed to FDA and its parent HHS department, on 2009-05-19. Its official title is “Novartis Pharmaceuticals Corp. et al.; Withdrawal of Approval of 92 New Drug Applications and 49 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin and Sermorelin.

Source: Federal Register via GovInfo ↗

→

Literature metadata · Semax

PubMed record PMID 19441725

PeptideScanner retained PubMed bibliographic metadata for PMID 19441725 at 2026-07-30T22:27:39.905Z. PubMed recorded a metadata revision date of 2009-05-15 and an Entrez history date of 2009-05-16. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

March 2009

3 records

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00051558

PeptideScanner retained ClinicalTrials.gov record NCT00051558 at 2026-07-30T22:26:45.005Z. Its registry update date was 2009-03-12, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

→

Regulatory · Liraglutide

Federal Register notice E9-5024

The Federal Register published notice E9-5024, attributed to FDA and its parent HHS department, on 2009-03-10. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Liraglutide.

Source: Federal Register via GovInfo ↗

→

February 2009

2 records

Clinical trials · Lanreotide

ClinicalTrials.gov record NCT00565097

PeptideScanner retained ClinicalTrials.gov record NCT00565097 at 2026-07-30T22:26:45.013Z. Its registry update date was 2009-02-17, and PeptideScanner's reviewed identity mapping was lanreotide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Bivalirudin

ClinicalTrials.gov record NCT00448461

PeptideScanner retained ClinicalTrials.gov record NCT00448461 at 2026-11-15T21:58:19.888Z. Its registry update date was 2009-02-10, and PeptideScanner's reviewed identity mapping was bivalirudin.

Source: ClinicalTrials.gov ↗

→